These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability. Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503 [TBL] [Abstract][Full Text] [Related]
4. Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer. Yagi T; Baba Y; Okadome K; Kiyozumi Y; Hiyoshi Y; Ishimoto T; Iwatsuki M; Miyamoto Y; Yoshida N; Watanabe M; Komohara Y; Baba H Eur J Cancer; 2019 Apr; 111():38-49. PubMed ID: 30822683 [TBL] [Abstract][Full Text] [Related]
5. PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma. Deng R; Lu J; Liu X; Peng XH; Wang J; Li XP Cancer Manag Res; 2020; 12():11585-11596. PubMed ID: 33209062 [TBL] [Abstract][Full Text] [Related]
6. Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer. Shinohara H; Kobayashi M; Hayashi K; Nogawa D; Asakawa A; Ohata Y; Kubota K; Takahashi H; Yamada M; Tokunaga M; Kinugasa Y; Oda G; Nakagawa T; Onishi I; Kinowaki Y; Kurata M; Ohashi K; Kitagawa M; Yamamoto K Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362023 [TBL] [Abstract][Full Text] [Related]
7. Programmed Cell Death Ligand 1 Expression in CD163 + Tumor-associated Macrophages in Cancer Gland Rupture Microenvironment. Baş Y; Yilmaz B; Acar SF; Karadağ İ Appl Immunohistochem Mol Morphol; 2024 Apr; 32(4):176-182. PubMed ID: 38314768 [TBL] [Abstract][Full Text] [Related]
8. M2-type tumor-associated macrophages upregulated PD-L1 expression in cervical cancer via the PI3K/AKT pathway. Guo F; Kong W; Li D; Zhao G; Anwar M; Xia F; Zhang Y; Ma C; Ma X Eur J Med Res; 2024 Jul; 29(1):357. PubMed ID: 38970071 [TBL] [Abstract][Full Text] [Related]
9. High-grade B-cell lymphomas with MYC and BCL2 translocations lack tumor-associated macrophages and PD-L1 expression: A possible noninflamed subgroup. Breinholt MF; Oliveira DVNP; Klausen TW; Gang AO; Schejbel L; Pedersen MØ; Elbaek MV; Clasen-Linde E; Nielsen SL; Knudsen H; Høgdall E; Nørgaard P Hematol Oncol; 2021 Aug; 39(3):284-292. PubMed ID: 33480087 [TBL] [Abstract][Full Text] [Related]
10. Expression of PD-L1, indoleamine 2,3-dioxygenase and the immune microenvironment in gastric adenocarcinoma. Patil PA; Blakely AM; Lombardo KA; Machan JT; Miner TJ; Wang LJ; Marwaha AS; Matoso A Histopathology; 2018 Jul; 73(1):124-136. PubMed ID: 29489025 [TBL] [Abstract][Full Text] [Related]
11. The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy. Jin S; Xu B; Yu L; Fu Y; Wu H; Fan X; Wei J; Liu B Oncotarget; 2017 Jun; 8(24):38850-38862. PubMed ID: 28418918 [TBL] [Abstract][Full Text] [Related]
12. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1. Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569 [TBL] [Abstract][Full Text] [Related]
13. Macrophages in Oral Carcinomas: Relationship with Cancer Stem Cell Markers and PD-L1 Expression. Suárez-Sánchez FJ; Lequerica-Fernández P; Suárez-Canto J; Rodrigo JP; Rodriguez-Santamarta T; Domínguez-Iglesias F; García-Pedrero JM; de Vicente JC Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630659 [TBL] [Abstract][Full Text] [Related]
14. PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type. Menguy S; Prochazkova-Carlotti M; Beylot-Barry M; Saltel F; Vergier B; Merlio JP; Pham-Ledard A Am J Surg Pathol; 2018 Mar; 42(3):326-334. PubMed ID: 29112015 [TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages and PD-L1 in prostate cancer: a possible key to unlocking immunotherapy efficacy. Wang J; Wu W; Yuan T; Wang L; Zang L; Liu Q; Wang L; Huo X; Huo B; Tang Y; Wang H; Zhao Z Aging (Albany NY); 2024 Jan; 16(1):445-465. PubMed ID: 38189834 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma. Zhang Y; Du W; Chen Z; Xiang C Exp Cell Res; 2017 Oct; 359(2):449-457. PubMed ID: 28830685 [TBL] [Abstract][Full Text] [Related]
17. The expression of C-MYC in gastric adenocarcinoma is associated with PD-L1 and FOXP3 expression: C-MYC overexpression is a good prognostic factor. Won KY; Kim GY; Kim HK; Song MJ; Choi SI; Bae GE; Lim SJ Pathol Res Pract; 2019 Nov; 215(11):152639. PubMed ID: 31582185 [TBL] [Abstract][Full Text] [Related]